Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
about
The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution ExperienceFirst-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY.The treatment of CML at an environment with limited resources.Effectiveness of Three Prognostic Scoring Systems in Predicting the Response and Outcome in Pediatric Chronic Myeloid Leukemia Chronic Phase on Frontline Imatinib.Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
P2860
Impact of risk score calculations in choosing front-line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phase.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of risk score calculati ...... leukemia in the chronic phase.
@en
type
label
Impact of risk score calculati ...... leukemia in the chronic phase.
@en
prefLabel
Impact of risk score calculati ...... leukemia in the chronic phase.
@en
P2860
P356
P1476
Impact of risk score calculati ...... leukemia in the chronic phase.
@en
P2093
Bipin N Savani
P2860
P304
P356
10.1111/EJH.12356
P50
P577
2014-05-16T00:00:00Z